aid: relay-tx
name: Relay Therapeutics
description: >-
  Relay Therapeutics is a Cambridge, Massachusetts clinical-stage precision
  medicines company (NASDAQ: RLAY) using protein motion to drug historically
  intractable oncology and genetic-disease targets. Its Dynamo platform
  combines full-length protein engineering, cryo-EM, ambient-temperature
  X-ray crystallography, long-timescale molecular dynamics, machine learning,
  virtual screening, activity- and ligand-based screening, and an ML-powered
  DNA-encoded library (REL-DEL) to design molecules against conformational
  states that static structures miss. The clinical pipeline is led by
  zovegalisib (RLY-2608), described as the first allosteric, pan-mutant,
  isoform-selective PI3K-alpha inhibitor, in Phase 3 for HR+/HER2- breast
  cancer and Phase 1/2 for vascular anomalies and PROS; RLY-8161, an NRAS-
  selective inhibitor, is in Phase 1/2 for NRAS-mutant solid tumors; an
  alpha-galactosidase A non-inhibitory chaperone for Fabry disease is in
  discovery; lirafugratinib (RLY-4008, FGFR2) was out-licensed to Elevar
  Therapeutics in December 2024. Relay has no public developer API, SDK, or
  open-source release; the Dynamo platform is proprietary internal R&D
  tooling, and the company's GitHub organization currently has no public
  repositories. The commercial surface is therapeutic candidates, clinical
  partnerships, and out-licensing rather than data products.
type: Index
position: Provider
access: 3rd-Party
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/apis-json-logo.jpg
tags:
  - Drug Discovery
  - Precision Medicine
  - Oncology
  - Genetic Disease
  - Protein Motion
  - Computational Chemistry
  - Molecular Dynamics
  - Cryo-EM
  - Machine Learning
  - DNA-Encoded Libraries
  - Allosteric Inhibitors
  - PI3K-Alpha
  - NRAS
  - FGFR2
  - Fabry Disease
  - Biotechnology
  - Clinical Stage
url: https://raw.githubusercontent.com/api-evangelist/relay-tx/refs/heads/main/apis.yml
created: '2026-05-24'
modified: '2026-05-24'
specificationVersion: '0.20'
apis: []
common:
  - type: DomainSecurity
    url: security/relay-tx-domain-security.yml
  - type: Website
    url: https://relaytx.com
  - type: Science
    url: https://relaytx.com/science/
  - type: DynamoPlatform
    url: https://relaytx.com/dynamo-platform/
  - type: Pipeline
    url: https://relaytx.com/pipeline/
  - type: Publications
    url: https://relaytx.com/publications/
  - type: Patients
    url: https://relaytx.com/patients/
  - type: Careers
    url: https://relaytx.com/careers/
  - type: Contact
    url: https://relaytx.com/contact/
  - type: InvestorRelations
    url: https://ir.relaytx.com
  - type: GitHub
    url: https://github.com/relaytx
  - type: LinkedIn
    url: https://www.linkedin.com/company/relay-therapeutics/
  - type: Twitter
    url: https://twitter.com/relaytx
maintainers:
  - FN: Kin Lane
    email: kin@apievangelist.com